ENTITY
Sun Pharmaceutical Industries

Sun Pharmaceutical Industries (SUNP IN)

143
Analysis
Health CareIndia
Sun Pharmaceutical Industries Limited manufactures and markets pharmaceuticals for domestic and international distribution. The Company's pharmaceutical portfolio includes drugs in the areas of diabetes, cardiology, neurology, psychiatry and gastroenterology.
more
Refresh
01 Jun 2018 17:08

Sun Pharma Specialty Research Pipeline – A Game Changer

Sun Pharmaceutical Indus (SUNP IN) currently has 2 specialty research products in the US market (Odomzo, Bromsite) and 4 approvals pending launch...

Logo
184 Views
Share
13 Apr 2018 15:14

IPCA Labs- The Revival Story

Ipca Laboratories Ltd (IPCA IN) is a fully integrated Indian pharmaceutical company. In FY17 45% of its revenues came from Indian dosage business,...

Logo
182 Views
Share
12 Jan 2018 09:51

BBSP Equity Asia Weekly Research 10th January 2018

Mid Term Country Allocation (Tactical view) in terms of Relative Value vs MXAP• HSCEI/MXAP ratio is moving in a range pattern. Therefore downgrade...

Logo
BBSP Asia
320 Views
Share
28 Dec 2017 23:24

Emerging Markets: Outlook and Recommendations

Today's report provides a synopsis of the technical state of emerging markets, along with actionable countries and a wide variety of bottom-up...

Logo
169 Views
Share
30 Nov 2017 02:29

Emerging Markets: Technical Strategy & Reccommendations

Today’s report provides a top-down synopsis of the technical condition of emerging markets across the globe, and includes a wide variety of...

Logo
968 Views
Share
x